Epizyme is Pharmaceuticals in United States that focus on commercializing novel business. Founded in 2007. They cover business area such as Epizyme Inc, treatment, cancer, novel epigenetic medicine, its product candidate, tazemetostat, an inhibitor, Phase II clinical trial, patient, NHL, mesothelioma, escalation, child, additional program, pinometostat, an intravenously administer small molecule inhibitor, acute leukemias.
2007
( 18 years old in 2025 )
Commercializing Novel
-
400 Technology Square
4th Floor
Cambridge, MA 02139
United States
Private
Epizyme Inctreatmentcancernovel epigenetic medicineits product candidatetazemetostatan inhibitorPhase II clinical trialpatientNHLmesotheliomaescalationchildadditional programpinometostatan intravenously administer small molecule inhibitoracute leukemias
* We use standard office opening hours in near Epizyme's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Epizyme is Pharmaceuticals business from United States that founded in 2007 (18 years old in 2025), Epizyme business is focusing on Commercializing Novel.
Epizyme headquarter office and corporate office address is located in 400 Technology Square 4th Floor Cambridge, MA 02139 United States.
Epizyme was founded in United States.
In 2025, Epizyme is currently focus on commercializing novel sector.
Above is snippet of Google Trends for "commercializing novel" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Epizyme, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
